nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Mycophenolic acid—systemic scleroderma	0.359	0.444	CbGbCtD
Indacaterol—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.201	0.248	CbGbCtD
Indacaterol—ABCB1—Lisinopril—systemic scleroderma	0.0675	0.0835	CbGbCtD
Indacaterol—ABCB1—Captopril—systemic scleroderma	0.0505	0.0625	CbGbCtD
Indacaterol—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0398	0.0492	CbGbCtD
Indacaterol—ABCB1—Prednisone—systemic scleroderma	0.0318	0.0394	CbGbCtD
Indacaterol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0238	0.0295	CbGbCtD
Indacaterol—CYP3A4—Prednisone—systemic scleroderma	0.0191	0.0236	CbGbCtD
Indacaterol—ABCB1—Methotrexate—systemic scleroderma	0.016	0.0197	CbGbCtD
Indacaterol—Pneumonia—Leflunomide—systemic scleroderma	0.000896	0.00466	CcSEcCtD
Indacaterol—Infestation NOS—Leflunomide—systemic scleroderma	0.000891	0.00464	CcSEcCtD
Indacaterol—Infestation—Leflunomide—systemic scleroderma	0.000891	0.00464	CcSEcCtD
Indacaterol—Nasopharyngitis—Lisinopril—systemic scleroderma	0.000888	0.00462	CcSEcCtD
Indacaterol—Tachycardia—Pentoxifylline—systemic scleroderma	0.000888	0.00462	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.000886	0.00461	CcSEcCtD
Indacaterol—Skin disorder—Pentoxifylline—systemic scleroderma	0.000883	0.0046	CcSEcCtD
Indacaterol—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00086	0.00447	CcSEcCtD
Indacaterol—Asthma—Lisinopril—systemic scleroderma	0.000858	0.00447	CcSEcCtD
Indacaterol—Pneumonia—Mycophenolic acid—systemic scleroderma	0.000855	0.00445	CcSEcCtD
Indacaterol—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.00085	0.00442	CcSEcCtD
Indacaterol—Infestation—Mycophenolic acid—systemic scleroderma	0.00085	0.00442	CcSEcCtD
Indacaterol—Bronchospasm—Lisinopril—systemic scleroderma	0.000844	0.00439	CcSEcCtD
Indacaterol—Cough—Mometasone—systemic scleroderma	0.000839	0.00437	CcSEcCtD
Indacaterol—Angina pectoris—Lisinopril—systemic scleroderma	0.000836	0.00435	CcSEcCtD
Indacaterol—Sinusitis—Leflunomide—systemic scleroderma	0.000836	0.00435	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.000829	0.00431	CcSEcCtD
Indacaterol—Myalgia—Mometasone—systemic scleroderma	0.000819	0.00426	CcSEcCtD
Indacaterol—Chest pain—Mometasone—systemic scleroderma	0.000819	0.00426	CcSEcCtD
Indacaterol—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000811	0.00422	CcSEcCtD
Indacaterol—Dry mouth—Mometasone—systemic scleroderma	0.000801	0.00417	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.000798	0.00415	CcSEcCtD
Indacaterol—Sinusitis—Mycophenolic acid—systemic scleroderma	0.000797	0.00415	CcSEcCtD
Indacaterol—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.000792	0.00412	CcSEcCtD
Indacaterol—Oedema peripheral—Leflunomide—systemic scleroderma	0.000788	0.0041	CcSEcCtD
Indacaterol—Connective tissue disorder—Leflunomide—systemic scleroderma	0.000786	0.00409	CcSEcCtD
Indacaterol—Anaemia—Captopril—systemic scleroderma	0.00078	0.00406	CcSEcCtD
Indacaterol—Infection—Mometasone—systemic scleroderma	0.00078	0.00406	CcSEcCtD
Indacaterol—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000774	0.00403	CcSEcCtD
Indacaterol—Pneumonia—Lisinopril—systemic scleroderma	0.00077	0.00401	CcSEcCtD
Indacaterol—Immune system disorder—Azathioprine—systemic scleroderma	0.000765	0.00398	CcSEcCtD
Indacaterol—Mediastinal disorder—Azathioprine—systemic scleroderma	0.000763	0.00397	CcSEcCtD
Indacaterol—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000752	0.00391	CcSEcCtD
Indacaterol—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000751	0.00391	CcSEcCtD
Indacaterol—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.000749	0.0039	CcSEcCtD
Indacaterol—Palpitations—Captopril—systemic scleroderma	0.000746	0.00388	CcSEcCtD
Indacaterol—Cardiac disorder—Leflunomide—systemic scleroderma	0.000742	0.00386	CcSEcCtD
Indacaterol—Cough—Captopril—systemic scleroderma	0.000737	0.00384	CcSEcCtD
Indacaterol—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.000733	0.00381	CcSEcCtD
Indacaterol—Immune system disorder—Leflunomide—systemic scleroderma	0.000722	0.00376	CcSEcCtD
Indacaterol—Mediastinal disorder—Leflunomide—systemic scleroderma	0.000721	0.00375	CcSEcCtD
Indacaterol—Chest pain—Captopril—systemic scleroderma	0.000719	0.00374	CcSEcCtD
Indacaterol—Myalgia—Captopril—systemic scleroderma	0.000719	0.00374	CcSEcCtD
Indacaterol—Sinusitis—Lisinopril—systemic scleroderma	0.000718	0.00374	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000715	0.00372	CcSEcCtD
Indacaterol—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000708	0.00368	CcSEcCtD
Indacaterol—Paraesthesia—Mometasone—systemic scleroderma	0.000705	0.00367	CcSEcCtD
Indacaterol—Dry mouth—Captopril—systemic scleroderma	0.000703	0.00366	CcSEcCtD
Indacaterol—Dyspnoea—Mometasone—systemic scleroderma	0.0007	0.00364	CcSEcCtD
Indacaterol—Malnutrition—Leflunomide—systemic scleroderma	0.000696	0.00362	CcSEcCtD
Indacaterol—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000687	0.00358	CcSEcCtD
Indacaterol—Anaemia—Azathioprine—systemic scleroderma	0.000681	0.00355	CcSEcCtD
Indacaterol—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00353	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisone—systemic scleroderma	0.000678	0.00353	CcSEcCtD
Indacaterol—Oedema peripheral—Lisinopril—systemic scleroderma	0.000677	0.00352	CcSEcCtD
Indacaterol—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.000674	0.00351	CcSEcCtD
Indacaterol—Tachycardia—Captopril—systemic scleroderma	0.000673	0.0035	CcSEcCtD
Indacaterol—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00349	CcSEcCtD
Indacaterol—Infestation—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00349	CcSEcCtD
Indacaterol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00067	0.00349	CcSEcCtD
Indacaterol—Muscle spasms—Leflunomide—systemic scleroderma	0.000669	0.00348	CcSEcCtD
Indacaterol—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000664	0.00346	CcSEcCtD
Indacaterol—Pruritus—Pentoxifylline—systemic scleroderma	0.000643	0.00335	CcSEcCtD
Indacaterol—Anaemia—Leflunomide—systemic scleroderma	0.000643	0.00335	CcSEcCtD
Indacaterol—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000638	0.00332	CcSEcCtD
Indacaterol—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000629	0.00327	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000628	0.00327	CcSEcCtD
Indacaterol—Myalgia—Azathioprine—systemic scleroderma	0.000627	0.00327	CcSEcCtD
Indacaterol—Vertigo—Leflunomide—systemic scleroderma	0.000625	0.00326	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000623	0.00324	CcSEcCtD
Indacaterol—Tremor—Mycophenolic acid—systemic scleroderma	0.000622	0.00324	CcSEcCtD
Indacaterol—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000619	0.00322	CcSEcCtD
Indacaterol—Paraesthesia—Captopril—systemic scleroderma	0.000619	0.00322	CcSEcCtD
Indacaterol—Palpitations—Leflunomide—systemic scleroderma	0.000615	0.0032	CcSEcCtD
Indacaterol—Dyspnoea—Captopril—systemic scleroderma	0.000614	0.0032	CcSEcCtD
Indacaterol—Anaemia—Mycophenolic acid—systemic scleroderma	0.000614	0.00319	CcSEcCtD
Indacaterol—Cough—Leflunomide—systemic scleroderma	0.000607	0.00316	CcSEcCtD
Indacaterol—Dizziness—Pentoxifylline—systemic scleroderma	0.000601	0.00313	CcSEcCtD
Indacaterol—Malnutrition—Lisinopril—systemic scleroderma	0.000598	0.00311	CcSEcCtD
Indacaterol—Infection—Azathioprine—systemic scleroderma	0.000598	0.00311	CcSEcCtD
Indacaterol—Vertigo—Mycophenolic acid—systemic scleroderma	0.000597	0.00311	CcSEcCtD
Indacaterol—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00309	CcSEcCtD
Indacaterol—Myalgia—Leflunomide—systemic scleroderma	0.000593	0.00308	CcSEcCtD
Indacaterol—Chest pain—Leflunomide—systemic scleroderma	0.000593	0.00308	CcSEcCtD
Indacaterol—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000591	0.00308	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000588	0.00306	CcSEcCtD
Indacaterol—Palpitations—Mycophenolic acid—systemic scleroderma	0.000587	0.00305	CcSEcCtD
Indacaterol—Skin disorder—Azathioprine—systemic scleroderma	0.000584	0.00304	CcSEcCtD
Indacaterol—Dry mouth—Leflunomide—systemic scleroderma	0.000579	0.00302	CcSEcCtD
Indacaterol—Cough—Mycophenolic acid—systemic scleroderma	0.000579	0.00302	CcSEcCtD
Indacaterol—Muscle spasms—Lisinopril—systemic scleroderma	0.000575	0.00299	CcSEcCtD
Indacaterol—Rash—Pentoxifylline—systemic scleroderma	0.000573	0.00298	CcSEcCtD
Indacaterol—Dermatitis—Pentoxifylline—systemic scleroderma	0.000573	0.00298	CcSEcCtD
Indacaterol—Headache—Pentoxifylline—systemic scleroderma	0.00057	0.00297	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000567	0.00295	CcSEcCtD
Indacaterol—Myalgia—Mycophenolic acid—systemic scleroderma	0.000565	0.00294	CcSEcCtD
Indacaterol—Chest pain—Mycophenolic acid—systemic scleroderma	0.000565	0.00294	CcSEcCtD
Indacaterol—Infection—Leflunomide—systemic scleroderma	0.000564	0.00294	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000561	0.00292	CcSEcCtD
Indacaterol—Tremor—Lisinopril—systemic scleroderma	0.00056	0.00292	CcSEcCtD
Indacaterol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00291	CcSEcCtD
Indacaterol—Nervous system disorder—Leflunomide—systemic scleroderma	0.000557	0.0029	CcSEcCtD
Indacaterol—Pruritus—Mometasone—systemic scleroderma	0.000555	0.00289	CcSEcCtD
Indacaterol—Tachycardia—Leflunomide—systemic scleroderma	0.000554	0.00289	CcSEcCtD
Indacaterol—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000553	0.00288	CcSEcCtD
Indacaterol—Anaemia—Lisinopril—systemic scleroderma	0.000553	0.00288	CcSEcCtD
Indacaterol—Skin disorder—Leflunomide—systemic scleroderma	0.000552	0.00287	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000548	0.00285	CcSEcCtD
Indacaterol—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00282	CcSEcCtD
Indacaterol—Nausea—Pentoxifylline—systemic scleroderma	0.00054	0.00281	CcSEcCtD
Indacaterol—Infection—Mycophenolic acid—systemic scleroderma	0.000538	0.0028	CcSEcCtD
Indacaterol—Vertigo—Lisinopril—systemic scleroderma	0.000537	0.0028	CcSEcCtD
Indacaterol—Hypokalaemia—Prednisone—systemic scleroderma	0.000537	0.00279	CcSEcCtD
Indacaterol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000531	0.00277	CcSEcCtD
Indacaterol—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000529	0.00275	CcSEcCtD
Indacaterol—Palpitations—Lisinopril—systemic scleroderma	0.000528	0.00275	CcSEcCtD
Indacaterol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000526	0.00274	CcSEcCtD
Indacaterol—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000524	0.00273	CcSEcCtD
Indacaterol—Cough—Lisinopril—systemic scleroderma	0.000522	0.00272	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000519	0.0027	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000518	0.00269	CcSEcCtD
Indacaterol—Paraesthesia—Leflunomide—systemic scleroderma	0.00051	0.00266	CcSEcCtD
Indacaterol—Chest pain—Lisinopril—systemic scleroderma	0.000509	0.00265	CcSEcCtD
Indacaterol—Myalgia—Lisinopril—systemic scleroderma	0.000509	0.00265	CcSEcCtD
Indacaterol—Dyspnoea—Leflunomide—systemic scleroderma	0.000506	0.00264	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000506	0.00263	CcSEcCtD
Indacaterol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00262	CcSEcCtD
Indacaterol—Dry mouth—Lisinopril—systemic scleroderma	0.000498	0.00259	CcSEcCtD
Indacaterol—Rash—Mometasone—systemic scleroderma	0.000495	0.00258	CcSEcCtD
Indacaterol—Dermatitis—Mometasone—systemic scleroderma	0.000494	0.00257	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000494	0.00257	CcSEcCtD
Indacaterol—Headache—Mometasone—systemic scleroderma	0.000492	0.00256	CcSEcCtD
Indacaterol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00256	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00049	0.00255	CcSEcCtD
Indacaterol—Pruritus—Captopril—systemic scleroderma	0.000488	0.00254	CcSEcCtD
Indacaterol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000487	0.00253	CcSEcCtD
Indacaterol—Infection—Lisinopril—systemic scleroderma	0.000485	0.00252	CcSEcCtD
Indacaterol—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00252	CcSEcCtD
Indacaterol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000483	0.00251	CcSEcCtD
Indacaterol—Tachycardia—Lisinopril—systemic scleroderma	0.000476	0.00248	CcSEcCtD
Indacaterol—Skin disorder—Lisinopril—systemic scleroderma	0.000474	0.00247	CcSEcCtD
Indacaterol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000471	0.00245	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000468	0.00244	CcSEcCtD
Indacaterol—Nausea—Mometasone—systemic scleroderma	0.000466	0.00243	CcSEcCtD
Indacaterol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000463	0.00241	CcSEcCtD
Indacaterol—Hyperglycaemia—Prednisone—systemic scleroderma	0.00046	0.00239	CcSEcCtD
Indacaterol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00238	CcSEcCtD
Indacaterol—Dizziness—Captopril—systemic scleroderma	0.000456	0.00237	CcSEcCtD
Indacaterol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00232	CcSEcCtD
Indacaterol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00232	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000445	0.00231	CcSEcCtD
Indacaterol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000443	0.00231	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00231	CcSEcCtD
Indacaterol—Paraesthesia—Lisinopril—systemic scleroderma	0.000438	0.00228	CcSEcCtD
Indacaterol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00227	CcSEcCtD
Indacaterol—Dyspnoea—Lisinopril—systemic scleroderma	0.000435	0.00227	CcSEcCtD
Indacaterol—Rash—Captopril—systemic scleroderma	0.000435	0.00226	CcSEcCtD
Indacaterol—Dermatitis—Captopril—systemic scleroderma	0.000434	0.00226	CcSEcCtD
Indacaterol—Headache—Captopril—systemic scleroderma	0.000432	0.00225	CcSEcCtD
Indacaterol—Asthma—Methotrexate—systemic scleroderma	0.000426	0.00222	CcSEcCtD
Indacaterol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00221	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000421	0.00219	CcSEcCtD
Indacaterol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00218	CcSEcCtD
Indacaterol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000418	0.00218	CcSEcCtD
Indacaterol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000417	0.00217	CcSEcCtD
Indacaterol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00216	CcSEcCtD
Indacaterol—Nausea—Captopril—systemic scleroderma	0.000409	0.00213	CcSEcCtD
Indacaterol—Pruritus—Leflunomide—systemic scleroderma	0.000402	0.00209	CcSEcCtD
Indacaterol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000401	0.00209	CcSEcCtD
Indacaterol—Dizziness—Azathioprine—systemic scleroderma	0.000398	0.00207	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000396	0.00206	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00203	CcSEcCtD
Indacaterol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000384	0.002	CcSEcCtD
Indacaterol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000383	0.002	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—systemic scleroderma	0.000382	0.00199	CcSEcCtD
Indacaterol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00198	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—systemic scleroderma	0.00038	0.00198	CcSEcCtD
Indacaterol—Infestation—Methotrexate—systemic scleroderma	0.00038	0.00198	CcSEcCtD
Indacaterol—Rash—Azathioprine—systemic scleroderma	0.000379	0.00197	CcSEcCtD
Indacaterol—Dermatitis—Azathioprine—systemic scleroderma	0.000379	0.00197	CcSEcCtD
Indacaterol—Headache—Azathioprine—systemic scleroderma	0.000377	0.00196	CcSEcCtD
Indacaterol—Dizziness—Leflunomide—systemic scleroderma	0.000376	0.00196	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000369	0.00192	CcSEcCtD
Indacaterol—Immune system disorder—Prednisone—systemic scleroderma	0.000369	0.00192	CcSEcCtD
Indacaterol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00036	0.00187	CcSEcCtD
Indacaterol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000358	0.00187	CcSEcCtD
Indacaterol—Rash—Leflunomide—systemic scleroderma	0.000358	0.00186	CcSEcCtD
Indacaterol—Dermatitis—Leflunomide—systemic scleroderma	0.000358	0.00186	CcSEcCtD
Indacaterol—Nausea—Azathioprine—systemic scleroderma	0.000357	0.00186	CcSEcCtD
Indacaterol—Headache—Leflunomide—systemic scleroderma	0.000356	0.00185	CcSEcCtD
Indacaterol—Malnutrition—Prednisone—systemic scleroderma	0.000355	0.00185	CcSEcCtD
Indacaterol—Pruritus—Lisinopril—systemic scleroderma	0.000345	0.0018	CcSEcCtD
Indacaterol—Rash—Mycophenolic acid—systemic scleroderma	0.000342	0.00178	CcSEcCtD
Indacaterol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000341	0.00178	CcSEcCtD
Indacaterol—Headache—Mycophenolic acid—systemic scleroderma	0.000339	0.00177	CcSEcCtD
Indacaterol—Nausea—Leflunomide—systemic scleroderma	0.000337	0.00176	CcSEcCtD
Indacaterol—Anaemia—Prednisone—systemic scleroderma	0.000328	0.00171	CcSEcCtD
Indacaterol—Dizziness—Lisinopril—systemic scleroderma	0.000323	0.00168	CcSEcCtD
Indacaterol—Nausea—Mycophenolic acid—systemic scleroderma	0.000322	0.00168	CcSEcCtD
Indacaterol—Vertigo—Prednisone—systemic scleroderma	0.000319	0.00166	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000316	0.00165	CcSEcCtD
Indacaterol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00164	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—systemic scleroderma	0.000308	0.0016	CcSEcCtD
Indacaterol—Rash—Lisinopril—systemic scleroderma	0.000308	0.0016	CcSEcCtD
Indacaterol—Dermatitis—Lisinopril—systemic scleroderma	0.000307	0.0016	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000307	0.0016	CcSEcCtD
Indacaterol—Headache—Lisinopril—systemic scleroderma	0.000306	0.00159	CcSEcCtD
Indacaterol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00158	CcSEcCtD
Indacaterol—Myalgia—Prednisone—systemic scleroderma	0.000302	0.00157	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.0003	0.00156	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—systemic scleroderma	0.000297	0.00155	CcSEcCtD
Indacaterol—Nausea—Lisinopril—systemic scleroderma	0.00029	0.00151	CcSEcCtD
Indacaterol—Infection—Prednisone—systemic scleroderma	0.000288	0.0015	CcSEcCtD
Indacaterol—Nervous system disorder—Prednisone—systemic scleroderma	0.000284	0.00148	CcSEcCtD
Indacaterol—Tachycardia—Prednisone—systemic scleroderma	0.000283	0.00147	CcSEcCtD
Indacaterol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00147	CcSEcCtD
Indacaterol—Skin disorder—Prednisone—systemic scleroderma	0.000282	0.00147	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—systemic scleroderma	0.000274	0.00143	CcSEcCtD
Indacaterol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00027	0.0014	CcSEcCtD
Indacaterol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000269	0.0014	CcSEcCtD
Indacaterol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00139	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—systemic scleroderma	0.000267	0.00139	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000264	0.00137	CcSEcCtD
Indacaterol—Paraesthesia—Prednisone—systemic scleroderma	0.00026	0.00136	CcSEcCtD
Indacaterol—Cough—Methotrexate—systemic scleroderma	0.000259	0.00135	CcSEcCtD
Indacaterol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00132	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—systemic scleroderma	0.000253	0.00132	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—systemic scleroderma	0.000253	0.00132	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000251	0.00131	CcSEcCtD
Indacaterol—Infection—Methotrexate—systemic scleroderma	0.000241	0.00125	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000238	0.00124	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—systemic scleroderma	0.000235	0.00122	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000221	0.00115	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—systemic scleroderma	0.000218	0.00113	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—systemic scleroderma	0.000216	0.00112	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisone—systemic scleroderma	0.000214	0.00111	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000209	0.00109	CcSEcCtD
Indacaterol—Pruritus—Prednisone—systemic scleroderma	0.000205	0.00107	CcSEcCtD
Indacaterol—Dizziness—Prednisone—systemic scleroderma	0.000192	0.000998	CcSEcCtD
Indacaterol—Rash—Prednisone—systemic scleroderma	0.000183	0.000951	CcSEcCtD
Indacaterol—Dermatitis—Prednisone—systemic scleroderma	0.000183	0.000951	CcSEcCtD
Indacaterol—Headache—Prednisone—systemic scleroderma	0.000182	0.000945	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000178	0.000929	CcSEcCtD
Indacaterol—Nausea—Prednisone—systemic scleroderma	0.000172	0.000896	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—systemic scleroderma	0.000171	0.000892	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—systemic scleroderma	0.00016	0.000834	CcSEcCtD
Indacaterol—Rash—Methotrexate—systemic scleroderma	0.000153	0.000795	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—systemic scleroderma	0.000153	0.000794	CcSEcCtD
Indacaterol—Headache—Methotrexate—systemic scleroderma	0.000152	0.00079	CcSEcCtD
Indacaterol—Nausea—Methotrexate—systemic scleroderma	0.000144	0.000749	CcSEcCtD
